Sanofi-aventis acquired Genzyme for $21 billion
On Feb. 15, 2011, Sanofi-aventis announced it would acquired Genzyme for $74 a share in cash or $21.1…
On Feb. 15, 2011, Sanofi-aventis announced it would acquired Genzyme for $74 a share in cash or $21.1…
On Oct. 28, 2010, Emergent BioSolutions announced it had completed the acquisition of Seatte-based Trubion Pharmaceutical for upfront…
On Jul. 22, 2010, MDRNA announced that MDRNA shareholders approved the issuance of shares of MDRNA common stock…
On Mar. 26, 2009, Roche completed its acquisition of Genentech for $46.8 billion pursuant to a short-form merger…
On Aug. 20, 2008, Sonus Pharmaceuticals was acquired by OncoGenex Technologies in a reverse merger transaction worth $10.36…
On Jul. 22, 2008, Bentley Pharmaceuticals was acquired by Teva Pharmaceutical Industries. At closing, Bentley consisted solely of…
On May 21, 2008, the North Carolina School of Pharmacy was renamed the Eshelman School of Pharmacy in…
On Dec. 12, 2007, Merck voluntarily recalled 1.2 million doses of Haemophilus influenzae type b (Hib) vaccines due…
on Oct. 15, 2007, the annual report from the National Cancer Institute (NCI) showed that cancer death rates…
On Aug. 20, 2007, researchers from Stanford University announced they had identified a pattern of gene expression shared…
On Apr. 12, 2007, Cody Laboratories was acquired by the Lannett Company based in Philadelphia, Pennsylvania. In 2006,…
On Apr. 12, 2007, Cody Labs became one of only seven companies in the U.S. to be granted…
On Jan. 29, 2007, Eli Lilly announced it had completed its acqusition of ICOS Corp. for $2.3 billion…
On Jan. 9, 2007, the U.S. Food and Drug Administration (FDA) announced it had approved a refrigerated form…
On Jan.2, 2007, Merck announced that it had completed its acquisition of Sirna Therapeutics for $1.1 billion in…
In 2007, the Vanderbilt Center for Neuroscience Drug Discovery was established, combining the expertise of four groups of…
In 2007, Cocrystal Discovery, now known as Cocrystal Pharma, was founded in Bothell as a pharmaceutical company with…
On Oct. 18, 2006, ICOS announced it had signed an agreement to be acquired by Eli Lilly and…
On Oct. 18, 2006, Trubion Pharmaceutical completed its IPO of 4,000,000 shares of common stock at $13.00 per…
On Aug. 11, 2006, Gilead Sciences announced that it had completed its acquisition of Corus Pharma for $365…
On Aug. 1, 2006, the Frances Langford Heart Center opened its doors bringing open-heart surgery and interventional cardiology…
On Jun. 27, 2006, Johnsonᅠ &ᅠ Johnson announced it had acquired Pfizer Consumer Healthcare for $16.6 billion, which…
In 2006, Stealth BioTherapeutics was established as an innovative biopharmaceutical company developing therapies to treat mitochondrial dysfunction associated…
In 2006, Calistoga Pharmaceuticals was founded as a Seattle-based spin-off from ICOS Corp. that was dedicated to developing…
On Jul. 12, 2005, Corixa Corp., based on First Hill in Seattle, was acquired by Glaxosmithkline (GSK) for…
On Feb. 15, 2005, in response to concerns about the safety of a number of prescription medicines, the…
On Aug. 24, 2004, Eli Lilly and Company launched Cymbalta (duloxetine HC), a new treatment for major depression…
On May 20, 2004, the Medicare Prescription Drug Improvement and Modernization Act, signed in 2003, required among other…
In 2004, Merck announced a voluntary worldwide withdrawal of Vioxx (rofecoxib) because of an increased risk of heart…
In 2004, the Emergency Use Authorization (EUA) program was established in 2004, when the Project BioShield Act, among…